Liang, Deguang
Jiang, Xuejun http://orcid.org/0000-0002-8670-3828
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA166413, R01CA258622, P30 CA008748)
DH | NIHR | Public Health Research Programme (R01CA204232)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
Article History
First Online: 19 January 2023
Competing interests
: D.L. is an inventor of a patent relevant to autophagy. X.J. is an inventor of patents relevant to cell death and autophagy. He is also a consultant and equity holder of Exarta Therapeutics and Lime Therapeutics.